Correction: Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity (Proceedings of the National Academy of Sciences of the United States of America (2011) 108 (8785-8790) DOI: 10.1073/pnas.1100769108);Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 21, 2011, Pages 8785-8790

  Dash, Rupesh ^a   Azab, Belal ^a   Quinn, Bridget A ^a   Shen, Xuening ^a   Wang, Xiang Yang ^a,c   Das, Swadesh K ^a   Rahmani, Mohamed ^b   Wei, Jun ^e   Hedvat, Michael ^a,e   Dent, Paul ^a,c   Dmitriev, Igor P ^d   Curiel, David T ^d   Grant, Steven ^a,b,c   Wu, Bainan ^e   Stebbins, John L ^e   Pellecchia, Maurizio ^e   Reed, John C ^e   Sarkar, Devanand ^a,c   Fisher, Paul B ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; BI 97C1; BIM PROTEIN; INTERLEUKIN 24; KI 67 ANTIGEN; PROTEIN BAK; PROTEIN BAX; PROTEIN MCL 1; SABUTOCLAX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MITOCHONDRION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TROPISM; TUMOR XENOGRAFT;

ADENOVIRIDAE; MUS; MUS MUSCULUS;

EID: 79957689156     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1706353114     Document Type: Erratum

References (25)

1. Damber JEAG, Aus G (2008) Prostate cancer. Lancet 371:1710-1721.
2. Dash R, et al. (2010) mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev 21:381-391.
3. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB (1995) Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486. (Pubitemid 26023815)
4. Dash R, et al. (2010) Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine. Cancer Res 70:5034-5045.
5. Cunningham CC, et al. (2005) Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 11:149-159. (Pubitemid 40012009)
6. Gupta P, et al. (2006) BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 66:8182-8191. (Pubitemid 44299186)
7. Yacoub A, et al. (2010) Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation- associated gene-7/interleukin- 24-induced killing in ovarian carcinoma cells. Mol Pharmacol 77:298-310.
8. Hamed HA, et al. (2010) Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma. Mol Ther 18: 1130-1142.
9. Day CL, et al. (2005) Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem 280:4738-4744. (Pubitemid 40288644)
10. Oltersdorf T, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677-681. (Pubitemid 40825512)
11. Wei J, et al. (2010) BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. J Med Chem 53:4166-4176.
12. Wei J, et al. (2009) Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. J Med Chem 52:4511-4523.
13. Wei J, et al. (2009) Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins. Mol Cancer Ther 8:904-913, and erratum (2009) 8:2076.
14. Dash R, et al. (2010) Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Ther 17:447-456.
15. Lebedeva IV, et al. (2003) Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 22:8758-8773. (Pubitemid 38010500)
16. Willis SN, et al. (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305. (Pubitemid 41003019)
17. She QB, et al. (2005) The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 8:287-297.
18. Djavaheri-Mergny M, Maiuri MC, Kroemer G (2010) Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 29:1717-1719.
19. Ellwood-Yen K, et al. (2003) Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4:223-238. (Pubitemid 37163836)
20. Greco A, et al. (2010) Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther 18:295-306.
21. Dash R, et al. (2011) Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic. Discov Med 11:46-56.
22. Kuwana T, et al. (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17:525-535. (Pubitemid 40269117)
23. Han J, Goldstein LA, Hou W, Rabinowich H (2007) Functional linkage between NOXA and Bim in mitochondrial apoptotic events. J Biol Chem 282:16223-16231. (Pubitemid 47100385)
24. Yacoub A, et al. (2008) Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Mol Cancer Ther 7:297-313. (Pubitemid 351302524)
25. Rahmani M, et al. (2009) The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways. Blood 114:4507-4516.